WitrynaImatinib (STI571) Mesylate inhibits c-Kit autophosphorylation, activation of MAPK, … Witryna----- imatinib saladex imatinib low blood pressure imatinib canada + gist imatinib vs hydroxyurea imatinib mesylate msds imatinib mesylate drugs imatinib pubme imatinib mode of action imatinib edema mechanism imatinib canada mastercard imatinib gist imatinib price in usa

Safety Data Sheet

WitrynaImatinib is approximately 95% bound to human plasma proteins, mainly albumin and alpha1-acid glycoprotein. The drug is eliminated predominantly via the bile in the form of metabolites, one of which (CGP 74588) shows comparable pharmacological activity to the parent drug. The faecal to urinary excretion ratio is approximately 5:1. WitrynaImatinib Add to My Records Monograph ID: M6213. Title: Imatinib Molecular Formula: C 29 H 31 N 7 O Molecular Weight: 493.62 Percent Composition: C 70.56%, H 6.33%, N 19.86%, O 3.24% ... iron weapons

MATERIAL SAFETY DATA SHEET - MedicinesFAQ

Witryna10 lis 2024 · Imatinib mesylate Iupac Name：methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide CAS No.: 220127-57-1 Molecular Weight：589.715 Modify Date.: 2024-11-10 15:55 Introduction: In May 2001, the FDA approved imatinib as a … WitrynaCustomer Interaction Center (MSDS requests): 1-888-669-6682 For Technical … Witryna15 wrz 2006 · Survival rates with imatinib mesylate were significantly better than with interferon-α within each of the CML prognostic risks groups. By multivariate analysis, imatinib mesylate therapy was identified as an independent favorable prognostic factor, after accounting for the impact of pretreatment factors (hazard ratio, 0.44; P < .01). By ... port stephens resort accommodation